Literature DB >> 12062784

Using ambulance attendances to recruit people who have experienced non-fatal heroin overdose.

Paul Dietze1, Craig Fry, Sandra Sunjic, Gabriele Bammer, Deborah Zador, Damien Jolley, Greg Rumbold.   

Abstract

AIMS: To trial two novel methods of recruiting people who experience non-fatal heroin overdose through the ambulance service.
SETTING: Melbourne and Sydney, Australia.
METHODS: In Melbourne potential participants were given numbered contact cards by ambulance paramedics after revival, while in Sydney potential participants were approached after revival by a researcher who travelled with ambulance paramedics to the overdose scene.
RESULTS: In Melbourne 281 cards were distributed during the period 1 June 1998-31 December 1998 and a subsequent contact rate of 24% was achieved with 14% attending a subsequent interview. In Sydney there were 170 initial contacts of which 139 (82%) answered a series of questions asked at the scene (the remainder either ineligible or incapable of answering questions) with 48 (35%) also attending for follow-up interviews.
CONCLUSIONS: Recruitment through contact with ambulance services is a novel method of recruiting heroin users for research into non-fatal heroin overdose with advantages over other methods of sampling for research on non-fatal heroin overdose. Copyright 2002 Elsevier Science Irealnd Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062784     DOI: 10.1016/s0376-8716(02)00009-1

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  2 in total

1.  EMS runs for suspected opioid overdose: implications for surveillance and prevention.

Authors:  Amy Knowlton; Brian W Weir; Frank Hazzard; Yngvild Olsen; Junette McWilliams; Julie Fields; Wade Gaasch
Journal:  Prehosp Emerg Care       Date:  2013 Jul-Sep       Impact factor: 3.077

2.  Intentional overdose among heroin overdose survivors.

Authors:  Penny Heale; Paul Dietze; Craig Fry
Journal:  J Urban Health       Date:  2003-06       Impact factor: 3.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.